Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Buckner, CD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 159 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Buckner, CD; Epstein, RB; Rudolph, RH; Clift, RA; Storb, R; Thomas, ED
      Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia (Reprinted from Blood, vol 35, pg 741-750, 1970)

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Buckner, CD
      This month in JSE

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    3. Buckner, CD
      This month in the JSE

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    4. Buckner, CD
      This month in JSE

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    5. Buckner, CD
      This month in JSE

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    6. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    7. Weaver, CH; Schulman, KA; Buckner, CD
      Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim

      BONE MARROW TRANSPLANTATION
    8. Buckner, CD
      This month in JSE

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    9. Buckner, CD
      Editorial board changes

      JOURNAL OF STRUCTURAL ENGINEERING-ASCE
    10. Weaver, CH; Schulman, KA; Wilson-Relyea, B; Birch, R; West, W; Buckner, CD
      Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

      JOURNAL OF CLINICAL ONCOLOGY
    11. Buckner, CD
      Remembering Bruno Speck

      ACTA HAEMATOLOGICA
    12. Buckner, CD
      Autologous bone marrow transplants to hematopoietic stem cell support withperipheral blood stem cells: A historical perspective

      JOURNAL OF HEMATOTHERAPY
    13. Demirer, T; Bensinger, WI; Buckner, CD
      Peripheral blood stem cell mobilization for high-dose chemotherapy

      JOURNAL OF HEMATOTHERAPY
    14. Schwartzberg, LS; Birch, R; Tauer, KW; Leff, R; Greco, FA; Hainsworth, J; Raefsky, E; McAneny, B; Weaver, Z; West, J; Buckner, CD; Weaver, CH
      Adjuvant dose-intense chemotherapy with peripheral blood stem cell supportin stage II-III breast cancer with five to nine involved axillary lymph nodes

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    15. Schwartzberg, LS; Weaver, CH; Birch, R; Giudice, R; Sobong, E; Schnell, F; Kalman, L; Buckner, CD
      Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    16. Schwartzberg, LS; Weaver, CH; Lewkow, L; McAneny, B; Zhen, B; Birch, R; West, WH; Tauer, KW; Buckner, CD
      High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast

      BONE MARROW TRANSPLANTATION
    17. Weaver, CH; Schwartzberg, LS; Zhen, B; Franco, C; Moore, M; Smith, R; White, L; Van Amburg, A; Hazelton, B; Buckner, CD
      Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of3 vs 4 g/m(2) of CY

      BONE MARROW TRANSPLANTATION
    18. WEAVER CH; TAUER K; ZHEN B; SCHWARTZBERG LS; HAZELTON B; WEAVER Z; LEWKOW L; ALLEN C; LONGIN K; BUCKNER CD
      2ND ATTEMPTS AT MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH INITIAL LOW CD34+ CELL YIELDS

      Journal of hematotherapy
    19. SCHWARTZBERG LS; WEAVER CH; BIRCH R; MANNER C; TAUER K; BEEKER T; MORGANIHRIG C; MACANENY B; LEFF R; SMITH R; HAINSWORTH J; GRECO T; SCHWERKOSKE J; MURPHY MN; BUCKNER CD
      A RANDOMIZED TRIAL OF 2 DOSES OF CYCLOPHOSPHAMIDE WITH ETOPOSIDE AND G-CSF FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN 318 PATIENTS WITH STAGE-II-STAGE-III BREAST-CANCER

      Journal of hematotherapy
    20. CLIFT RA; BUCKNER CD
      MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA

      Cancer investigation
    21. WILLIAMS O; DEMIRER T; LILLEBY K; BUCKNER CD; BENSINGER WI
      TEMPO OF HEMATOLOGIC RECOVERY CORRELATES WITH PERIPHERAL-BLOOD CD34-CELL MOBILIZATION( CELL LEVEL IN PATIENTS UNDERGOING STEM)

      Journal of clinical apheresis
    22. SCHWARTZBERG LS; BIRCH R; WEST WH; TAUER KW; WITTLIN F; LEFF R; CAMPOS L; RYMER W; CARTER P; MANGUM M; GRECO FA; HAINSWORTH J; RAEFSKY E; BLANCO R; BUCKNER CD; WEAVER CH
      SEQUENTIAL TREATMENT INCLUDING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK STAGE II-III BREAST-CANCER - OUTPATIENT ADMINISTRATION IN COMMUNITY CANCER CENTERS

      American journal of clinical oncology
    23. NEMUNAITIS J; BUCKNER CD; DORSEY KS; WILLIS D; MEYER W; APPELBAUM F
      RETROSPECTIVE ANALYSIS OF INFECTIOUS-DISEASE IN PATIENTS WHO RECEIVEDRECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR VERSUS PATIENTS NOT RECEIVING A CYTOKINE WHO UNDERWENT AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF LYMPHOID CANCER

      American journal of clinical oncology
    24. WEAVER CH; ZHEN B; SCHWARTZBERG L; WALKER C; UPTON S; BUCKNER CD
      A RANDOMIZED TRIAL OF MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS WITH CYCLOPHOSPHAMIDE, ETOPOSIDE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CISPLATIN IN PATIENTS WITH MALIGNANT-LYMPHOMA RECEIVING HIGH-DOSE CHEMOTHERAPY

      American journal of clinical oncology
    25. HOLMBERG LA; DEMIRER T; ROWLEY S; BUCKNER CD; GOODMAN G; MAZIARZ R; KLARNET J; ZUCKERMAN N; HARRER G; MCCLOSKEY R; GERSH R; GOLDBERG R; NICHOLS W; JACOBS A; WEIDEN P; MONTGOMERY P; RIVKIN S; APPELBAUM FR; BENSINGER WI
      HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/

      Bone marrow transplantation
    26. BIRCH R; WEAVER CH; CARSON K; BUCKNER CD
      A RANDOMIZED TRIAL OF ONCE VS TWICE-DAILY ADMINISTRATION OF INTRAVENOUS GRANISETRON WITH DEXAMETHOSONE IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND CARBOPLATIN

      Bone marrow transplantation
    27. WEAVER CH; ZHEN B; SCHWARTZBERG LS; LEFF R; MAGEE M; GEIER L; DEATON K; LEWKOW L; BUCKNER CD
      PHASE I-II EVALUATION OF RAPID-SEQUENCE TANDEM HIGH-DOSE MELPHALAN WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MULTIPLE-MYELOMA

      Bone marrow transplantation
    28. WEAVER CH; SCHWARTZBERG L; RHINEHART S; WEST J; ZHEN B; WEST WH; BUCKNER CD
      HIGH-DOSE CHEMOTHERAPY WITH BUCY OR BEAC AND UNPURGED PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA

      Bone marrow transplantation
    29. WEAVER CH; MOSS T; SCHWARTZBERG LS; ZHEN B; WEST J; RHINEHART S; CAMPOS L; BEEKER T; LAUTERSZTAIN L; MESSINO M; BUCKNER CD
      HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH BREAST-CANCER - EVALUATION OFINFUSING PERIPHERAL-BLOOD STEM-CELLS CONTAINING OCCULT TUMOR-CELLS

      Bone marrow transplantation
    30. WEAVER CH; ZHEN B; BUCKNER CD
      TREATMENT OF PATIENTS WITH MALIGNANT-LYMPHOMA WITH MINI-BEAM REDUCES THE YIELD OF CD34(-BLOOD STEM-CELLS() PERIPHERAL)

      Bone marrow transplantation
    31. WEAVER CH; BIRCH R; GRECO FA; SCHWARTZBERG L; MCANENY B; MOORE M; OVIATT D; REDMOND J; GEORGE C; ALBERICO T; JOHNSON P; BUCKNER CD
      MOBILIZATION AND HARVESTING OF PERIPHERAL-BLOOD STEM-CELLS - RANDOMIZED EVALUATIONS OF DIFFERENT DOSES OF FILGRASTIM

      British Journal of Haematology
    32. CLIFT RA; BUCKNER CD; APPELBAUM FR; SULLIVAN KM; STORB R; THOMAS ED
      LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF 2 IRRADIATION REGIMENS FOR PATIENTS RECEIVING ALLOGENEIC MARROW TRANSPLANTS DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA

      Blood
    33. BENSINGER WI; BUCKNER CD; GAHRTON G
      ALLOGENEIC STEM-CELL TRANSPLANTATION FOR MULTIPLE-MYELOMA

      Hematology/oncology clinics of North America
    34. DEMIRER T; BUCKNER CD; STORER B; LILLEBY K; ROWLEY S; CLIFT R; APPELBAUM FR; STORB R; BENSINGER WI
      EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR

      Journal of clinical oncology
    35. WEAVER CH; SCHWARTZBERG L; ZHEN B; MANGUM M; LEFF R; TAUER K; ROSENBERG A; PENDERGRASS K; KAYWIN P; HAINSWORTH J; GRECO FA; WEST WH; BUCKNER CD
      HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA - RESULTS OF OUTPATIENT TREATMENT IN COMMUNITY CANCER CENTERS

      Bone marrow transplantation
    36. WEAVER CH; GRECO FA; HAINSWORTH JD; ZHEN B; BALDWIN P; WITTLIN F; LEWIS M; WEST WH; SCHWARTZBERG L; BUCKNER CD
      A PHASE I-II STUDY OF HIGH-DOSE MELPHALAN, MITOXANTRONE AND CARBOPLATIN WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH ADVANCED OVARIAN OR BREAST-CARCINOMA

      Bone marrow transplantation
    37. WEAVER CH; WEST WH; SCHWARTZBERG LS; ALBERICO T; LEFF R; GRECO FA; HAINSWORTH J; BIRCH R; MCANENY B; MAGEE M; RAEFSKY E; KALMAN L; BUCKNER CD
      INDUCTION, MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC), HIGH-DOSE CHEMOTHERAPY AND PBSC INFUSION IN PATIENTS WITH UNTREATED STAGE-IVBREAST-CANCER - OUTCOMES BY INTENT TO TREAT ANALYSES

      Bone marrow transplantation
    38. WEAVER CH; SCHWARTZBERG LS; HAINSWORTH J; GRECO FA; LI W; BUCKNER CD; WEST WH
      TREATMENT-RELATED MORTALITY IN 1000 CONSECUTIVE PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN COMMUNITY CANCER CENTERS

      Bone marrow transplantation
    39. ROBINSON N; BENYUNES MC; THOMPSON JA; YORK A; PETERSDORF S; PRESS O; LINDGREN C; CHAUNCEY T; BUCKNER CD; BENSINGER WI; APPELBAUM FR; FEFER A
      INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCY - A PHASE I II STUDY/

      Bone marrow transplantation
    40. BENSINGER WI; SCHIFFMAN KS; HOLMBERG L; APPELBAUM FR; MAZIARZ R; MONTGOMERY P; ELLIS E; RIVKIN S; WEIDEN P; LILLEBY K; ROWLEY S; PETERSDORF S; KLARNET JP; NICHOLS W; HERTLER A; MCCROSKEY R; WEAVER CH; BUCKNER CD
      HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER

      Bone marrow transplantation
    41. WEAVER CH; POTZ J; REDMOND J; TAUER K; SCHWARTZBERG LS; KAYWIN P; DRAPKIN R; GRANT B; UNGER P; ALLEN C; LONGIN K; ZHEN B; HAZELTON B; BUCKNER CD
      ENGRAFTMENT AND OUTCOMES OF PATIENTS RECEIVING MYELOABLATIVE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS WITH A LOW CD34(+) CELL CONTENT

      Bone marrow transplantation
    42. WEAVER CH; SCHWARTZBERG LS; BIRCH R; GRECO FA; RHINEHART S; HAINSWORTH J; BEEKER T; PRICE H; GEIER L; FOSTER J; WEST J; HAZELTON B; BUCKNER CD
      COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER THE ADMINISTRATION OF CYCLOPHOSPHAMIDE, ETOPOSIDE, AND GRANULOCYTE-COLONY-STIMULATINGFACTOR - AN ANALYSIS OF 497 PATIENTS

      Transfusion
    43. BUCKNER CD; MORONEY JT; DESMOND DW; STERN Y; MOHR JP
      POSTERIOR THALAMIC INFARCTION WITH CORTICAL DIASCHISIS AS A BASIS FORDEMENTIA

      Neurology
    44. BIRCH R; WEAVER CH; CARSON K; PHELPS C; BUCKNER CD
      A RANDOMIZED TRIAL OF GRANISETRON ADMINISTERED IV AT 12 OR 24-HOUR INTERVALS IN PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY AND BLOOD STEM-CELL INFUSION

      Blood
    45. HOLMBERG LA; STORER B; SANDMAIER BM; BUCKNER CD; BENSINGER WJ; ROWLEY SD
      AUTOLOGOUS TRANSPLANT USING INTERLEUKIN-2 (IL2) TREATED PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN PATIENTS WITH ADVANCED MALIGNANCIES

      Blood
    46. HOLMBERG LA; DEMIRER T; SCIFFMAN K; ROWLEY SD; BUCKNER CD; GOODMAN G; MAZIARZ R; APPELBAUM F; BENSINGER WI
      HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELTT) FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/

      Blood
    47. SLATTERY JT; CLIFT RA; BUCKNER CD; RADICH J; STORER B; BENSINGER WI; SOLL E; ANASETTI C; BOWDEN R; BRYANT E; CHAUNCEY T; DEEG HJ; DONEY KC; FLOWERS M; GOOLEY T; HANSEN JA; MARTIN PJ; MCDONALD GB; NASH R; PETERSDORF EW; SANDERS JE; SCHOCH G; STEWART P; STORB R; SULLIVAN KM; THOMAS ED; WITHERSPOON RP; APPELBAUM FR
      MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION

      Blood
    48. STORB R; LEISENRING W; ANASETTI C; APPELBAUM FR; BUCKNER CD; BENSINGER WI; CHAUNCEY T; CLIFT RA; DEEG HJ; DONEY KC; FLOWERS MED; HANSEN JA; MARTIN PJ; SANDERS KM; WITHERSPOON RP
      LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN

      Blood
    49. BENSINGER WI; CLIFT RA; ANASETTI C; APPELBAUM FA; DEMIRER T; ROWLEY S; SANDMAIER BM; TOROKSTORB B; STORB R; BUCKNER CD
      TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR

      Stem cells
    50. DEMIRER T; BUCKNER CD; BENSINGER WI
      OPTIMIZATION OF PERIPHERAL FLOOD STEM-CELL MOBILIZATION

      Stem cells
    51. BENSINGER WI; ROWLEY SD; DEMIRER T; LILLEBY K; SCHIFFMAN K; CLIFT RA; APPELBAUM FR; FEFER A; BARNETT T; STORB R; CHAUNCEY T; MAZIARZ RT; KLARNET J; MCSWEENEY P; HOLMBERG L; MALONEY DG; WEAVER CH; BUCKNER CD
      HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL INFUSION FOR PATIENTS WITH MULTIPLE-MYELOMA

      Journal of clinical oncology
    52. SLATTERY JT; KALHORN TF; MCDONALD GB; LAMBERT K; BUCKNER CD; BENSINGER WI; ANASETTI C; APPELBAUM FR
      CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS

      Journal of clinical oncology
    53. ANDERSON JE; APPELBAUM FR; SCHOCH G; GOOLEY T; ANASETTI C; BENSINGER WI; BRYANT E; BUCKNER CD; CHAUNCEY T; CLIFT RA; DEEG HJ; DONEY K; FLOWERS M; HANSEN JA; MARTIN PJ; MATTHEWS DC; NASH RA; SANDERS JE; SHULMAN H; SULLIVAN KM; WITHERSPOON RP; STORB R
      ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS

      Journal of clinical oncology
    54. HUSS R; DEEG HJ; GOOLEY T; BRYANT E; LEISENRING W; CLIFT R; BUCKNER CD; MARTIN P; STORB R; APPELBAUM FR
      EFFECT OF MIXED CHIMERISM ON GRAFT-VERSUS-HOST DISEASE, DISEASE RECURRENCE AND SURVIVAL AFTER HLA-IDENTICAL MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA OR CHRONIC MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    55. SLATTERY JT; SANDERS JE; BUCKNER CD; SCHAFFER RL; LAMBERT KW; LANGER FP; ANASETTI C; BENSINGER WI; FISHER LD; APPELBAUM FR; HANSEN JA
      GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS (VOL 16, PG 31, 1995)

      Bone marrow transplantation
    56. BENSINGER WI; DEMIRER T; BUCKNER CD; APPELBAUM FR; STORB R; LILLEBY K; WEIDEN P; BLUMING AZ; FEFER A
      SYNGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA

      Bone marrow transplantation
    57. DEMIRER T; PETERSEN FB; BENSINGER WI; APPELBAUM FR; FEFER A; ROWLEY S; SANDERS J; CHAUNCEY T; STORB R; LILLEBY K; BUCKNER CD
      AUTOLOGOUS TRANSPLANTATION WITH PERIPHERAL-BLOOD STEM-CELLS COLLECTEDAFTER GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    58. BRUNVAND MW; BENSINGER WI; SOLL E; WEAVER CH; ROWLEY SD; APPELBAUM FR; LILLEBY K; CLIFT RA; GOOLEY TA; PRESS OW; FEFER A; STORB R; SANDERS JE; MARTIN PL; CHAUNCEY T; MAZIARZ RT; ZUCKERMAN N; MONTGOMERY P; DORN R; WEIDEN PL; DEMIRER T; HOLMBERG LA; SCHIFFMAN K; MCSWEENEY PA; MALONEY DG; BUCKNER CD
      HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS

      Bone marrow transplantation
    59. DEMIRER T; BUCKNER CD; GOOLEY T; APPELBAUM FR; ROWLEY S; CHAUNCEY T; LILLEBY K; STORB R; BENSINGER WI
      FACTORS INFLUENCING COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH MULTIPLE-MYELOMA

      Bone marrow transplantation
    60. SCHIFFMAN KS; BENSINGER WI; APPELBAUM FR; ROWLEY S; LILLEBY K; CLIFT RA; WEAVER CH; DEMIRER T; SANDERS JE; PETERSDORF S; GOOLEY T; WEIDEN P; ZUCKERMAN N; MONTGOMERY P; MAZIARZ R; KLARNET JP; RIVKIN S; TRUEBLOOD K; STORB R; HOLMBERG L; BUCKNER CD
      PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE

      Bone marrow transplantation
    61. ATTARIAN H; BENSINGER WI; BUCKNER CD; MCDONALD DL; ROWLEY SD
      MICROBIAL-CONTAMINATION OF PERIPHERAL-BLOOD STEM-CELL COLLECTIONS

      Bone marrow transplantation
    62. DEMIRER T; BUCKNER CD; APPELBAUM FR; CLIFT R; STORB R; MYERSON D; LILLEBY K; ROWLEY S; BENSINGER WI
      HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER

      Bone marrow transplantation
    63. DEMIRER T; BUCKNER CD; APPELBAUM FR; BENSINGER WI; SANDERS J; LAMBERT K; CLIFT R; FEFER A; STORB R; SLATTERY JT
      BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR AUTOLOGOUS OR SYNGENEIC MARROW TRANSPLANTATION FOR ACUTE AND CHRONICMYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS

      Bone marrow transplantation
    64. DEMIRER T; BUCKNER CD; APPELBAUM FR; LAMBERT K; BENSINGER WI; CLIFT R; STORB R; SLATTERY JT
      BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR ALLOGENEIC MARROW TRANSPLANTATION IN ADVANCED ACUTE AND CHRONIC MYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS

      Bone marrow transplantation
    65. MASSUMOTO C; BENYUNES MC; SALE G; BEAUCHAMP M; YORK A; THOMPSON JA; BUCKNER CD; FEFER A
      CLOSE SIMULATION OF ACUTE GRAFT-VERSUS-HOST DISEASE BY INTERLEUKIN-2 ADMINISTERED AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCY

      Bone marrow transplantation
    66. ATTARIAN H; FENG Z; BUCKNER CD; MACLEOD B; ROWLEY SD
      LONG-TERM CRYOPRESERVATION OF BONE-MARROW FOR AUTOLOGOUS TRANSPLANTATION

      Bone marrow transplantation
    67. BENSINGER WI; BUCKNER CD; ROWLEY S; STORB R; APPELBAUM FR
      TREATMENT OF NORMAL DONORS WITH RECOMBINANT GROWTH-FACTORS FOR TRANSPLANTATION OF ALLOGENEIC BLOOD STEM-CELLS

      Bone marrow transplantation
    68. BENSINGER WI; BUCKNER CD; ROWLEY S; DEMIRER T; STORB R; APPELBAUM FA
      TRANSPLANTATION OF ALLOGENEIC CD34-BLOOD STEM-CELLS (PBSC) IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCY( PERIPHERAL)

      Bone marrow transplantation
    69. BENSINGER WI; BUCKNER CD; DEMIRER T; STORB R; APPELBAUM FA
      TRANSPLANTATION OF ALLOGENEIC PERIPHERAL BLOOD STEM CELLS

      Bone marrow transplantation
    70. ANDERSON JE; ANASETTI C; APPELBAUM FR; SCHOCH G; GOOLEY TA; HANSEN JA; BUCKNER CD; SANDERS JE; SULLIVAN KM; STORB R
      UNRELATED DONOR MARROW TRANSPLANTATION FOR MYELODYSPLASIA (MDS) AND MDS-RELATED ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    71. BENSINGER WI; BUCKNER CD; ANASETTI C; CLIFT R; STORB R; BARNETT T; CHAUNCEY T; SHULMAN H; APPELBAUM FR
      ALLOGENEIC MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - AN ANALYSIS OF RISK-FACTORS ON OUTCOME

      Blood
    72. BENSINGER WI; CLIFT R; MARTIN P; APPELBAUM FR; DEMIRER T; GOOLEY T; LILLEBY K; ROWLEY S; SANDERS J; STORB R; BUCKNER CD
      ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES - A RETROSPECTIVE COMPARISON WITH MARROW TRANSPLANTATION

      Blood
    73. MCSWEENEY PA; WELLS DA; SHULTS KE; NASH RA; BENSINGER WI; BUCKNER CD; LOKEN MR
      TUMOR-SPECIFIC ANEUPLOIDY NOT DETECTED IN CD19(-LYMPHOID CELLS FROM MYELOMA PATIENTS IN A MULTIDIMENSIONAL FLOW CYTOMETRIC ANALYSIS() B)

      Blood
    74. BENSINGER WI; BUCKNER CD; SHANNONDORCY K; ROWLEY S; APPELBAUM FR; BENYUNES M; CLIFT R; MARTIN P; DEMIRER T; STORB R; LEE M; SCHILLER G
      TRANSPLANTATION OF ALLOGENEIC CD34(-BLOOD STEM-CELLS IN PATIENTS WITHADVANCED HEMATOLOGIC MALIGNANCY() PERIPHERAL)

      Blood
    75. WEAVER CH; SCHWARTZBERG LS; UPTON S; BIRCH R; BUCKNER CD
      INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL COMPARING HIGH-ROSE BUSULFAN, MELPHALAN AND THIOTEPA (BUMELT) WITH CARMUSTINE, ETOPOSIDE, CYTOSINE-ARABINOSIDE AND CYCLOPHOSPHAMIDE (BEAC) FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL (PBSC) INFUSION IN PATIENTS WITH RELAPSED HODGKINS-DISEASE (HD)

      Blood
    76. WEAVER CH; SCHWARTZBERG LS; ZHEN B; HAZELTON B; BUCKNER CD
      ENGRAFTMENT IN PATIENTS RECEIVING MYELOABLATIVE THERAPY SUPPORTED WITH PBSC HAVING LOW CD34(+) CELL CONTENT

      Blood
    77. SCHWARTZBERG LS; BIRCH R; ANDREWS CR; BURKE L; HAZELTON B; MURPHY MN; BUCKNER CD; WEAVER CH
      A NEW DUAL-CHAMBER IMPLANTABLE INJECTION SYSTEM FOR LONG-TERM CANCER-CHEMOTHERAPY AND APHERESIS OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)

      Blood
    78. BENSINGER WI; ROWLEY S; LILLEBY K; CLIFT R; BUCKNER CD; KUNKEL L; MILLS B; CHAUNCEY T; STORB R; APPELBAUM FR
      REDUCTION IN GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER TRANSPLANTATION OF CD34 SELECTED, ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN OLDER PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

      Blood
    79. SANDERS JE; HAWLEY J; LEVY W; GOOLEY T; BUCKNER CD; DEEG HJ; DONEY K; STORB R; SULLIVAN K; WITHERSPOON R; APPELBAUM FR
      PREGNANCIES FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE WITH OR WITHOUT HIGH-DOSE BUSULFAN OR TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION

      Blood
    80. ANDERSON JE; APPELBAUM FR; SCHOCH G; GOOLEY T; ANASETTI C; BENSINGER WI; BRYANT E; BUCKNER CD; CHAUNCEY TR; CLIFT RA; DONEY K; FLOWERS M; HANSEN JA; MARTIN PJ; MATTHEWS DC; SANDERS JE; SHULMAN H; SULLIVAN KM; WITHERSPOON RP; STORB R
      ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS

      Blood
    81. BENSINGER WI; APPELBAUM FA; DEMIRER T; TOROKSTORB B; STORB R; BUCKNER CD
      TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS

      Stem cells
    82. DEMIRER T; ROWLEY S; BUCKNER CD; APPELBAUM FR; LILLEBY K; STORB R; SCHIFFMAN K; BENSINGER WI
      PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER PACLITAXEL, CYCLOPHOSPHAMIDE, AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH BREAST AND OVARIAN-CANCER

      Journal of clinical oncology
    83. DEMIRER T; WEAVER CH; BUCKNER CD; PETERSEN FB; BENSINGER WI; SANDERS J; CLIFT RA; LILLEBY K; ANASETTI C; MARTIN P; STORB R; CHAUNCEY T; DONEY K; SULLIVAN K; APPELBAUM FR
      HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY

      Journal of clinical oncology
    84. BENSINGER W; APPELBAUM F; ROWLEY S; STORB R; SANDERS J; LILLEBY K; GOOLEY T; DEMIRER T; SCHIFFMAN K; WEAVER C; CLIFT R; CHAUNCEY T; KLARNET J; MONTGOMERY P; PETERSDORF S; WEIDEN P; WITHERSPOON R; BUCKNER CD
      FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS

      Journal of clinical oncology
    85. DEMIRER T; PETERSEN FB; APPELBAUM FR; BARNETT TA; SANDERS J; DEEG HJ; STORB R; DONEY K; BENSINGER WI; SHANNONDORCY K; BUCKNER CD
      ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE AND ESCALATING DOSES OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN PATIENTS WITH ADVANCED LYMPHOID MALIGNANCIES - A PHASE I II TRIAL/

      International journal of radiation oncology, biology, physics
    86. BENYUNES MC; SULLIVAN KM; DEEG HJ; MORI M; MEYER W; FISHER L; BENSINGER R; JACK MK; HICKS J; WITHERSPOON R; BUCKNER CD; HANSEN JA; APPELBAUM FR; STORB R
      CATARACTS AFTER BONE-MARROW TRANSPLANTATION - LONG-TERM FOLLOW-UP OF ADULTS TREATED WITH FRACTIONATED TOTAL-BODY IRRADIATION

      International journal of radiation oncology, biology, physics
    87. DONEY K; BUCKNER CD; STORB R
      MARROW HARVESTING FROM DONORS GREATER-THAN-OR-EQUAL-TO-65 YEARS OF AGE

      Experimental hematology
    88. BENYUNES MC; HIGUCHI C; YORK A; LINDGREN C; THOMPSON JA; BUCKNER CD; FEFER A
      IMMUNOTHERAPY WITH INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATEDKILLER-CELLS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A FEASIBILITY TRIAL

      Bone marrow transplantation
    89. SLATTERY JT; SANDERS JE; BUCKNER CD; SCHAFFER RL; LAMBERT KW; LANGER FP; ANASETTI C; BENSINGER WI; FISHER LD; APPELBAUM FR; HANSEN JA
      GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS

      Bone marrow transplantation
    90. DEMIRER T; GOOLEY T; BUCKNER CD; PETERSEN FB; LILLEBY K; ROWLEY S; SANDERS J; STORB R; APPELBAUM FR; BENSINGER WI
      INFLUENCE OF TOTAL NUCLEATED CELL DOSE FROM MARROW HARVESTS ON OUTCOME IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA UNDERGOING AUTOLOGOUS TRANSPLANTATION

      Bone marrow transplantation
    91. DEMIRER T; BUCKNER CD; APPELBAUM FR; PETERSEN FB; ROWLEY S; WEAVER CH; LILLEBY K; SANDERS J; CHAUNCEY T; STORB R; SCHIFFMAN K; BENYUNES MC; FEFER A; MONTGOMERY P; BENSINGER WI
      RAPID ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION UTILIZING MARROW AND RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

      Bone marrow transplantation
    92. LANGENMAYER I; WEAVER C; BUCKNER CD; LILLEBY K; APPELBAUM FR; LONGIN K; ROWLEY S; STORB R; SINGER J; BENSINGER WI
      ENGRAFTMENT OF PATIENTS WITH LYMPHOID MALIGNANCIES TRANSPLANTED WITH AUTOLOGOUS BONE-MARROW, PERIPHERAL-BLOOD STEM-CELLS OR BOTH

      Bone marrow transplantation
    93. LYNCH MHE; PETERSEN FB; APPELBAUM FR; BENSINGER WI; CLIFT RA; STORB R; SANDERS JE; HANSEN JA; BUCKNER CD
      PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION AS A PREPARATORY REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES

      Bone marrow transplantation
    94. APPELBAUM FR; CLIFT R; RADICH J; ANASETTI C; BUCKNER CD
      BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Seminars in oncology
    95. BOECKH M; GOOLEY TA; REUSSER P; BUCKNER CD; BOWDEN RA
      FAILURE OF HIGH-DOSE ACYCLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER AUTOLOGOUS MARROW TRANSPLANTATION

      The Journal of infectious diseases
    96. BALDUZZI A; GOOLEY T; ANASETTI C; SANDERS JE; MARTIN PJ; PETERSDORF EW; APPELBAUM FR; BUCKNER CD; MATTHEWS D; STORB R; SULLIVAN KM; HANSEN JA
      UNRELATED DONOR MARROW TRANSPLANTATION IN CHILDREN

      Blood
    97. KALHS P; SCHWARZINGER I; ANDERSON G; MORI M; CLIFT RA; STORB R; BUCKNER CD; APPELBAUM FR; HANSEN JA; SULLIVAN KM
      A RETROSPECTIVE ANALYSIS OF THE LONG-TERM EFFECT OF SPLENECTOMY ON LATE INFECTIONS, GRAFT-VERSUS-HOST DISEASE, RELAPSE, AND SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    98. SOLL E; MASSUMOTO C; CLIFT RA; BUCKNER CD; APPELBAUM FR; STORB R; SALE G; HACKMAN R; MARTIN P
      RELEVANCE OF MARROW FIBROSIS IN BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF ENGRAFTMENT

      Blood
    99. BENSINGER WI; ROWLEY S; APPELBAUM FR; MILLS B; OLDHAM F; CHAUNCEY T; BUCKNER CD
      CD34 SELECTED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION IN OLDER PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES

      Blood
    100. DEMIRER T; BENSINGER WI; ROWLEY S; APPELBAUM FR; PETERSEN FB; CHAUNCEY T; FEFER A; BUCKNER CD
      COMPARISON OF GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) MOBILIZED PERIPHERAL-BLOOD STEM-CELLS (PBSC) AND BONE-MARROW FOR AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:55:07